DDMAC To Cornerstone: Zyflo CR Promotions Need Current Safety Labeling
Executive Summary
An FDA advertising violation letter for Cornerstone Therapeutics' asthma therapy Zyflo CR should serve to remind industry that providing outdated safety labeling with promotions is a sure way to draw the agency's regulatory scrutiny